CERo Therapeutics Holdings, Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CERO and other ETFs, options, and stocks.About CERO
CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. Its platform is designed to redirect patient-derived T cells to eliminate tumors, creating Chimeric Engulfment Receptor T (CER-T) cells used for spanning hematological malignancies and solid tumors.
CEOChristopher B. Ehrlich
CEOChristopher B. Ehrlich
Employees—
Employees—
HeadquartersOakland, California
HeadquartersOakland, California
Founded2021
Founded2021
Employees—
Employees—
CERO Key Statistics
Market cap4.79M
Market cap4.79M
Price-Earnings ratio-0.02
Price-Earnings ratio-0.02
Dividend yield—
Dividend yield—
Average volume562.59K
Average volume562.59K
High today$9.57
High today$9.57
Low today$9.22
Low today$9.22
Open price$9.35
Open price$9.35
Volume56.27K
Volume56.27K
52 Week high$895.40
52 Week high$895.40
52 Week low$6.71
52 Week low$6.71
CERO News
TipRanks 5d
CERo Therapeutics Completes Additional Series D FundingDon’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights...
People also own
Based on the portfolios of people who own CERO. This list is generated using Robinhood data, and it’s not a recommendation.